Dr. Engemann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2304 Wesvill Ct
Suite 240
Raleigh, NC 27607Phone+1 919-571-1567Fax+1 919-782-1472
Education & Training
- Duke University HospitalFellowship, Infectious Disease, 2000 - 2002
- Duke University HospitalResidency, Internal Medicine, 1996 - 1999
- Wayne State University School of MedicineClass of 1996
Certifications & Licensure
- NC State Medical License 1999 - 2025
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 1153 citationsBaricitinib plus Remdesivir for Hospitalized Adults with Covid-19.Andre C. Kalil, Thomas F. Patterson, Aneesh K. Mehta, Kay M. Tomashek, Cameron R. Wolfe
The New England Journal of Medicine. 2021-03-04 - 59 citationsRisk Factors for Postoperative Mediastinitis Due to Methicillin-Resistant Staphylococcus aureusE. S. Dodds Ashley, D. N. Carroll, John J. Engemann, Anthony D. Harris, Vance G. Fowler
Clinical Infectious Diseases. 2004-06-01 - 663 citationsAdverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infectionJohn J. Engemann, Yehuda Carmeli, Sara E. Cosgrove, Vance G. Fowler, Melissa Z. Bronstein
Clinical Infectious Diseases. 2003-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: